| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fingolimod Hydrochloride | FAERS: 13 | US FAERS | |
| 2 | Doxorubicin | FAERS: 2 | US FAERS | |
| 3 | pimecrolimus | FAERS: 2 | SIDER US FAERS | |
| 4 | regorafenib | FAERS: 2 | US FAERS | |
| 5 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 6 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 7 | Fluconazole | FAERS: 1 | US FAERS | |
| 8 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 9 | Mefloquine | FAERS: 1 | US FAERS | |
| 10 | Teriparatide | FAERS: 1 | US FAERS | |
| 11 | carfilzomib | FAERS: 1 | US FAERS | |
| 12 | Linezolid | OFFSIDES | ||
| 13 | NuvaRing | OFFSIDES | ||
| 14 | Streptomycin | OFFSIDES | ||
| 15 | Tacrolimus | SIDER | ||
| 16 | triazulenone | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.